๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Lisuride in de novo Parkinsonian patients: a four-year follow-up

โœ Scribed by P. Giovannini; G. Scigliano; I. Piccolo; P. Soliveri; I. Suchy; T. Caraceni


Book ID
114782689
Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
449 KB
Volume
77
Category
Article
ISSN
0001-6314

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Selegiline in de novo parkinsonian patie
โœ Prof. V. V. Myllylรค; K. A. Sotaniemi; J. A. Vuorinen; E. H. Heinonen ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 353 KB

Selegiline (L-deprenyl) has been recommended as an antiparkinsonian drug to be used as an adjunct to therapy with L-dopa, if and when L-dopa starts to lose its effect. However, initial selegiline monotherapy followed by L-dopa may be both effective and safe. A double-blind, placebo-controlled trial